The Valley Desk

NCT01073163 · Interventional trial

Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Overall registry status Completed

Phase 3

Conditions Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov